Alkem Laboratories Quarterly Results for Trading Insights
ALKEM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹779 Cr
QSept 2025
Alkem Laboratories Quarterly Results Key Highlights
- Revenue of ₹4,105 Cr in Sept 2025 (+24.8% vs Mar 2025, +15.7% vs Sept 2024)
- Net Profit of ₹779 Cr in Sept 2025 (+141.9% vs Mar 2025, +11.0% vs Sept 2024)
- EBITDA of ₹1,025 Cr in Sept 2025 (+90.9% vs Mar 2025)
- Operating Margin of 23.0% in Sept 2025 (+11.0pp vs Mar 2025)
- Earnings Per Share of ₹63.99 in Sept 2025 (+150.3% vs Mar 2025)
Alkem Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 4,105 | 3,290 | 3,521 | 3,549 | 3,024 | 24.8% | 15.7% |
| Net Profit (₹ Cr) | 779 | 322 | 668 | 702 | 305 | - | - |
| EBITDA (₹ Cr) | 1,025 | 537 | 889 | 887 | 478 | - | - |
| EPS (₹) | 63.99 | 25.57 | 55.56 | 57.60 | 24.55 | - | - |
| Operating Margin (%) | 23.0% | 12.0% | 22.0% | 22.0% | 13.0% | - | - |
Alkem Laboratories Share Price Trend Around Quarterly Results
Visualize Alkem Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Alkem Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Alkem Laboratories
Additional stock information and data for ALKEM
Revenue Trend (₹ Cr)
Sept 2024
3,549
Jun 2025
3,521
Mar 2025
3,290
Sept 2025
4,105
Net Profit Trend (₹ Cr)
Sept 2024
702
Jun 2025
668
Mar 2025
322
Sept 2025
779
Operating Margin Trend (%)
Sept 2024
22.0%
Jun 2025
22.0%
Mar 2025
12.0%
Sept 2025
23.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Alkem Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹391,547.47 Cr | 1704.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.1 |
|
Divis Laboratories
Sept 2025 |
₹160,887.23 Cr | 6054.5 | 2,860 | 689 | +7.1% | - | 24.1% | 233.1 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,071.99 Cr | 4023.5 | 3,219 | 591 | +11.3% | - | 18.4% | 229.4 |
|
Cipla
Sept 2025 |
₹110,697.00 Cr | 1326.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹103,126.93 Cr | 1240.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores